GlassScriptPhysician profile
Jennifer C Compton
NPI 1467457341
$5,321.04
in general payments reported to CMS, 2019-2025
42 companies · $1,255 in 2025
The $1,255 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $884 · 2022: $1,064 · 2023: $803 · 2024: $1,315 · 2025: $1,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,373.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $980.75 | 2021-2025 | |
| Novo Nordisk INC | $772.92 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $374.11 | 2022-2025 | |
| Lilly USA, LLC | $353.28 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $298.98 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $273.50 | 2021-2025 | |
| Glaxosmithkline, LLC. | $250.33 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $211.69 | 2021-2025 | Repatha, Otezla, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $208.67 | 2021-2025 | Trintellix |
| Axsome Therapeutics, INC. | $153.63 | 2023-2025 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.72 | 2021-2025 | Xifaxan |
| Esperion Therapeutics, INC. | $117.52 | 2021-2025 | Nexletol |
| Lundbeck LLC | $116.18 | 2021-2024 | Vyepti |
| Astellas Pharma US INC | $103.39 | 2023-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $100.60 | 2024-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Compton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.